Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2003;108:2911-2917
Published online before print December 1, 2003, doi: 10.1161/01.CIR.0000101917.80668.E1
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
108/23/2911    most recent
01.CIR.0000101917.80668.E1v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Reffelmann, T.
Right arrow Articles by Kloner, R. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Reffelmann, T.
Right arrow Articles by Kloner, R. A.
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*Cardiomyopathy
Related Collections
Right arrow Other Vascular biology

(Circulation. 2003;108:2911.)
© 2003 American Heart Association, Inc.


Basic Science Reports

No-Reflow Phenomenon Persists Long-Term After Ischemia/Reperfusion in the Rat and Predicts Infarct Expansion

Thorsten Reffelmann, MD; Sharon L. Hale, BS; Joan S. Dow, BS; Robert A. Kloner, MD, PhD

From the Heart Institute, Good Samaritan Hospital, Division of Cardiovascular Medicine, University of Southern California, Los Angeles.

Correspondence to Robert A. Kloner, The Heart Institute, Good Samaritan Hospital, University of Southern California, 1225 Wilshire Blvd, Los Angeles, CA 90017. E-mail rkloner{at}goodsam.org

Received June 18, 2002; de novo received May 27, 2003; revision received August 8, 2003; accepted August 8, 2003.

Background— No-reflow after reperfusion therapy for myocardial infarction is a strong predictor of clinical outcome. But its fate on a long-term basis and potential significance for infarct healing are not yet known.

Methods and Results— Twenty-nine female Fisher rats were subjected to 60 minutes of coronary occlusion followed by reperfusion. At 4 weeks, 15 survivors were euthanized after measurement of regional myocardial blood flow (radioactive microspheres) and in vivo staining of perfused tissue (0.5 mL 50% Uniperse blue IV). Infarct size (34.3±3.4%), scar thickness (1.19±0.10 mm), and infarct expansion index (0.51±0.04) were assessed from histological sections (2 additional exclusions because of failed occlusion). Regional myocardial blood flow in the reperfused infarct was reduced significantly compared with noninfarcted tissue (1.98±0.47 versus 4.55±0.86 mL · min-1 · g-1, P<0.003, apical slice, and 1.77±0.44 versus 5.34±0.38 mL · min-1 · g-1, P<0.0001, second slice), accompanied by a striking reduction of perfused capillaries within the infarct (n=23±4 versus 163±8 in the noninfarcted tissue, P<0.0001, microscopically assessed as capillaries containing blue particles per high-power field). Macroscopically, no-reflow areas were visible in 9 of 13 hearts. The number of perfused capillaries within the infarct correlated significantly with infarct expansion index (r=-0.76, P<0.003), infarct thickness (r=0.60, P<0.03), and the ratio of infarct to septum thickness (r=0.74, P<0.004).

Conclusions— The no-reflow phenomenon persists for 1 month after reperfusion and predicts worse scar thinning and infarct expansion. Thus, one might shift the "open-artery" hypothesis downstream to an "open-microvessel" hypothesis, relating infarct healing, infarct expansion, and outcome to the completeness of microvascular reperfusion above and beyond epicardial artery patency.


Key Words: blood flow • infarction • microcirculation • remodeling • echocardiography




This article has been cited by other articles:


Home page
J. Thorac. Cardiovasc. Surg.Home page
V. Dor, F. Civaia, C. Alexandrescu, and F. Montiglio
The post-myocardial infarction scarred ventricle and congestive heart failure: the preeminence of magnetic resonance imaging for preoperative, intraoperative, and postoperative assessment.
J. Thorac. Cardiovasc. Surg., December 1, 2008; 136(6): 1405 - 1412.
[Full Text] [PDF]


Home page
Circ. Res.Home page
R. A. Kloner and H. Hwang
New Insights Into the Open Artery Hypothesis
Circ. Res., July 3, 2008; 103(1): 1 - 3.
[Full Text] [PDF]


Home page
CirculationHome page
M. Salio, S. Chimenti, N. De Angelis, F. Molla, V. Maina, M. Nebuloni, F. Pasqualini, R. Latini, C. Garlanda, and A. Mantovani
Cardioprotective Function of the Long Pentraxin PTX3 in Acute Myocardial Infarction
Circulation, February 26, 2008; 117(8): 1055 - 1064.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
T. Freyman, G. Polin, H. Osman, J. Crary, M. Lu, L. Cheng, M. Palasis, and R. L. Wilensky
A quantitative, randomized study evaluating three methods of mesenchymal stem cell delivery following myocardial infarction
Eur. Heart J., May 1, 2006; 27(9): 1114 - 1122.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
E. J. van den Bos, B. M. E. Mees, M. C. de Waard, R. de Crom, and D. J. Duncker
A novel model of cryoinjury-induced myocardial infarction in the mouse: a comparison with coronary artery ligation
Am J Physiol Heart Circ Physiol, September 1, 2005; 289(3): H1291 - H1300.
[Abstract] [Full Text] [PDF]


Home page
Eur J EchocardiogrHome page
V. Bodi, J. Sanchis, A. Losada, M. P. Lopez-Lereu, D. Garcia, M. Pellicer, F. J. Chorro, and A. Llacer
Usefulness of quantitative intravenous myocardial contrast echocardiography to analyze microvasculature perfusion in patients with a recent myocardial infarction and an open infarct-related artery: comparison with intracoronary myocardial contrast echocardiography
Eur J Echocardiogr, June 1, 2005; 6(3): 164 - 174.
[Abstract] [Full Text] [PDF]


Home page
Br Med BullHome page
H. K. Eltzschig and C. D. Collard
Vascular ischaemia and reperfusion injury
Br. Med. Bull., October 19, 2004; 70(1): 71 - 86.
[Abstract] [Full Text] [PDF]


Home page
J CARDIOVASC PHARMACOL THERHome page
T. Reffemann and R. A. Kloner
Microvascular Alterations After Temporary Coronary Artery Occlusion: The No-Reflow Phenomenon
Journal of Cardiovascular Pharmacology and Therapeutics, July 1, 2004; 9(3): 163 - 172.
[Abstract] [PDF]